SYNEDGEN, INC.

Address

1420 N CLAREMONT BLVD STE 105D
CLAREMONT, CA, 91711-3583

http://www.synedgen.com

Information

DUNS: 830276353
# of Employees: 10

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Novel treatment for Crohn's disease and related inflammatory gastrointestinal disease

    Amount: $224,412.00

    DESCRIPTION provided by applicant Crohnandapos s disease is an inflammatory disorder of the gastrointestinal GI tract likely associated with a hyperactive immune response to commensal bacteria a ...

    SBIRPhase I2016Department of Health and Human Services
  2. Development of Technologies that Control Scar Formation after Burn Injuries

    Amount: $986,378.00

    Thermal injury is common in military conflicts as well as in civilian activities, and burn severity ranges from limited partial thickness to severe full thickness burns that can cover a significant po ...

    SBIRPhase II2016Department of Defense Defense Health Program
  3. Prevention and treatment of GI obstruction syndromes in cystic fibrosis

    Amount: $146,412.00

    DESCRIPTION provided by applicant Cystic fibrosis CF is a genetic disease resulting from a variety of defects of the cystic fibrosis transmembrane conductance regulator CFTR gene that is involv ...

    SBIRPhase I2015Department of Health and Human Services
  4. Effective New Topical Treatment to Reduce Scar Formation in Burns

    Amount: $870,530.00

    Thermal injury is common in military conflicts due primarily to the widespread use of explosive devices. Though scar formation is a natural process of wound healing, burns can produce scars that are e ...

    SBIRPhase II2014Defense Health Program Department of Defense
  5. Clinical Development of IPdR for Radiosensitization Period of Performance: 09/19/2014- 06/18/2015

    Amount: $196,707.00

    Radiotherapy is a well-established treatment for cancer, however pelvic radiotherapy can result in radiation proctitis, particularly after treatment of prostate or cervical cancer. In severe cases, ra ...

    SBIRPhase I2014Department of Health and Human Services
  6. Effective New Topical Treatment to Reduce Scar Formation in Burns

    Amount: $149,904.00

    Thermal injury is common in military conflicts due to primarily to the widespread use of explosive devices. Burns can produce scars that are excessive, physically debilitating and functionally damagin ...

    SBIRPhase I2013Department of Defense
  7. Rectal Medication Administration Device for Palliative Care

    Amount: $149,901.00

    DESCRIPTION (provided by applicant): Thick hyperviscous mucus and delayed mucociliary clearance are important elements underlying cystic fibrosis (CF) pathogenesis, but currently available therapeutic ...

    SBIRPhase I2013Department of Health and Human Services
  8. Antimicrobial and Regenerative Treatment for Oral Mucositis

    Amount: $1,963,826.00

    DESCRIPTION (provided by applicant): Oral mucositis is a frequent and painful complication of chemotherapy, radiotherapy and immune compromise. Mucositis is associated with significant morbidity incl ...

    SBIRPhase II2011Department of Health and Human Services
  9. Wound Decontamination for the Prevention and Treatment of Multi-drug Resistant Ba

    Amount: $99,638.00

    DESCRIPTION (provided by applicant): The frequency of multi-drug resistant infections is increasing at an alarming rate. Equally concerning is the limited therapeutic options available for effective t ...

    SBIRPhase I2010Department of Health and Human Services
  10. Prevention and Treatment of Oral Biofilms and Related Oral Disease by Soluble Chi

    Amount: $99,665.00

    DESCRIPTION (provided by applicant): A need remains for safe and effective, prophylactic and therapeutic treatments for controlling bacterial populations in dental plaque and treating periodontal dis ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government